These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 9184696)
1. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Li L; Krajewski S; Reed JC; Choi YS Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696 [TBL] [Abstract][Full Text] [Related]
2. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Lotem J; Sachs L Cell Growth Differ; 1995 Jun; 6(6):647-53. PubMed ID: 7669718 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Akbar AN; Borthwick NJ; Wickremasinghe RG; Panayoitidis P; Pilling D; Bofill M; Krajewski S; Reed JC; Salmon M Eur J Immunol; 1996 Feb; 26(2):294-9. PubMed ID: 8617294 [TBL] [Abstract][Full Text] [Related]
4. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Mapara MY; Bargou R; Zugck C; Döhner H; Ustaoglu F; Jonker RR; Krammer PH; Dörken B Eur J Immunol; 1993 Mar; 23(3):702-8. PubMed ID: 7680614 [TBL] [Abstract][Full Text] [Related]
5. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Choi MS; Holmann M; Atkins CJ; Klaus GG Eur J Immunol; 1996 Mar; 26(3):676-82. PubMed ID: 8605937 [TBL] [Abstract][Full Text] [Related]
6. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610 [TBL] [Abstract][Full Text] [Related]
8. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. Moulding DA; Akgul C; Derouet M; White MR; Edwards SW J Leukoc Biol; 2001 Nov; 70(5):783-92. PubMed ID: 11698499 [TBL] [Abstract][Full Text] [Related]
9. GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1. Klampfer L; Zhang J; Nimer SD Cytokine; 1999 Nov; 11(11):849-55. PubMed ID: 10547272 [TBL] [Abstract][Full Text] [Related]
10. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization. Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563 [TBL] [Abstract][Full Text] [Related]
11. Role of Bax in apoptosis of IL-3-dependent cells. Low W; Olmos-Centenera G; Madsen C; Leverrier Y; Collins MK Oncogene; 2001 Jul; 20(33):4476-83. PubMed ID: 11494143 [TBL] [Abstract][Full Text] [Related]
12. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609 [TBL] [Abstract][Full Text] [Related]
13. Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Lømo J; Smeland EB; Krajewski S; Reed JC; Blomhoff HK Cancer Res; 1996 Jan; 56(1):40-3. PubMed ID: 8548771 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Saltzman A; Munro R; Searfoss G; Franks C; Jaye M; Ivashchenko Y Exp Cell Res; 1998 Jul; 242(1):244-54. PubMed ID: 9665822 [TBL] [Abstract][Full Text] [Related]
15. The role of IL-10 in human B cell activation, proliferation, and differentiation. Itoh K; Hirohata S J Immunol; 1995 May; 154(9):4341-50. PubMed ID: 7722292 [TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. Broome HE; Dargan CM; Krajewski S; Reed JC J Immunol; 1995 Sep; 155(5):2311-7. PubMed ID: 7650367 [TBL] [Abstract][Full Text] [Related]
17. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Walker A; Taylor ST; Hickman JA; Dive C Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989 [TBL] [Abstract][Full Text] [Related]
18. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113 [TBL] [Abstract][Full Text] [Related]
19. Strength of signal through BCR determines the fate of cycling B cells by regulating the expression of the Bcl-2 family of survival proteins. Pittner BT; Snow EC Cell Immunol; 1998 May; 186(1):55-62. PubMed ID: 9637765 [TBL] [Abstract][Full Text] [Related]
20. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. Myklebust JH; Josefsen D; Blomhoff HK; Levy FO; Naderi S; Reed JC; Smeland EB J Cell Physiol; 1999 Jul; 180(1):71-80. PubMed ID: 10362019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]